Surface Oncology, Inc. Debt to Equity Ratio 2018-2023 | SURF
Current and historical debt to equity ratio values for Surface Oncology, Inc. (SURF) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Surface Oncology, Inc. debt/equity for the three months ending June 30, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-06-30 | $0.02B | $0.05B | 0.34 |
| 2023-03-31 | $0.06B | $0.08B | 0.81 |
| 2022-12-31 | $0.07B | $0.09B | 0.71 |
| 2022-09-30 | $0.07B | $0.11B | 0.61 |
| 2022-06-30 | $0.07B | $0.13B | 0.54 |
| 2022-03-31 | $0.07B | $0.15B | 0.48 |
| 2021-12-31 | $0.07B | $0.12B | 0.61 |
| 2021-09-30 | $0.06B | $0.13B | 0.44 |
| 2021-06-30 | $0.06B | $0.15B | 0.39 |
| 2021-03-31 | $0.06B | $0.16B | 0.35 |
| 2020-12-31 | $0.06B | $0.16B | 0.39 |
| 2020-09-30 | $0.06B | $0.09B | 0.68 |
| 2020-06-30 | $0.06B | $0.10B | 0.58 |
| 2020-03-31 | $0.05B | $0.08B | 0.61 |
| 2019-12-31 | $0.08B | $0.06B | 1.32 |
| 2019-09-30 | $0.07B | $0.07B | 1.02 |
| 2019-06-30 | $0.07B | $0.08B | 0.84 |
| 2019-03-31 | $0.07B | $0.10B | 0.70 |
| 2018-12-31 | $0.07B | $0.10B | 0.69 |
| 2018-09-30 | $0.08B | $0.11B | 0.76 |
| 2018-06-30 | $0.08B | $0.12B | 0.66 |
| 2018-03-31 | $0.13B | $-0.02B | -6.34 |
| 2017-12-31 | $0.15B | $-0.07B | -2.21 |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
| 2017-03-31 | $0.00B | 0.00 | |
